MannKind Corporation Common Stock (MNKD) Stock
NASDAQ · MNKD
3.54
Fundamentals
Market cap
$1.14B
Price / Earnings ratio
-26.4x
Price / Sales ratio
2.9x
Price / Book ratio
-17.1x
Return on assets
-0.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About MannKind Corporation Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees591
CEODr. Michael E. Castagna Pharm.D.
IPO DateJul 28, 2004
HeadquartersDanbury, CT
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Michael E. Castagna Pharm.D. | CEO & Director | 1976 |
| Mr. Christopher B. Prentiss M.B.A. | Chief Financial Officer | 1975 |
| Dr. David B. Thomson J.D., Ph.D. | Executive VP, General Counsel & Secretary | 1967 |
| Dr. Stuart A. Tross Ph.D. | Chief People & Workplace Officer | 1967 |
| Mr. Dominic Marasco R.Ph. | President of Endocrine Business Unit | 1972 |
| Mr. Sanjay Singh M.B.A. | Executive Vice President of Technical Operations | 1966 |
| Dr. Ajay Ahuja M.B.A., M.D. | Executive VP & Chief Medical Officer | 1970 |
| Dr. Wassim Fares M.D., M.Sc. | Senior VP and Therapeutic Area Head of Respiratory & (interim) Cariorenal | — |
Fundamentals
Valuation
Market cap$1.14B
Price-to-sales ratio2.92
Price-to-book value-17.13
Price-earnings ratio-26.40
Return on Equity46.00%
Return on Sales0.03%
Return on AssetsN/A
PEG ratio4.39
Earnings Per Share
Earnings Per Share$-0.13
Income Statement
Average volume3,129,571
EBITDA$29.02M
1 year high (52w)$6.51
1 year low (52w)$2.23
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



